NK

Neeraj Kumar

Active Director Director DIN 07628943
DIN 07628943 First appointment Oct 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Neeraj Kumar

Data last updated:

Neeraj Kumar is a Director at Kenbrio Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Kenbrio Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (FY 2024).

DIN 07628943
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2016
Oldest Company Age 10 yrs
Largest company Kenbrio Pharmaceuticals Private Limited · ₹1.05 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Oct 20162016₹1.05 Cr (FY 2024)Active

Board colleagues of Neeraj Kumar

NameDINCompanyDesignation
Rakesh Singh Salaria07628487Kenbrio Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kenbrio Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neeraj Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Kumar

Neeraj Kumar currently holds 1 directorship: Kenbrio Pharmaceuticals Private Limited (Director, since 13 Oct 2016, revenue ₹1.05 Cr (FY 2024)).

Neeraj Kumar was first appointed on 13 Oct 2016 as Director at Kenbrio Pharmaceuticals Private Limited.

The current boards of Neeraj Kumar's companies include Rakesh Singh Salaria (Kenbrio Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available